SCHEMBL3343387

SCHEMBL3343387

O=C1NCCC2=C1C(c1cccc(O)c1)NC(=S)N2

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.50
ALDH1A1 P00352 5/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
GUSB P08236 1/20 0.45
GAA P10253 2/20 0.43
KDM4E B2RXH2 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPT P10636 2/20 0.39
GPR174 Q9BXC1 1/20 0.39
LMNA P02545 1/20 0.38
TRPA1 O75762 2/20 0.37
KIF11 P52732 4/20 0.37
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
ABCC9 O60706 1/20 0.35
ABCC8 Q09428 1/20 0.35
KCNJ11 Q14654 1/20 0.35
KCNJ8 Q15842 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3344481 0.88 DHFR (0.52) DHFRALDH1A1MEN1KMT2AGUSB
(S)-Enastron SCHEMBL5177968 0.81 ALDH1A1 (0.72) DHFRALDH1A1MEN1KMT2AGUSB
SCHEMBL3338330 0.81 DHFR (0.50) DHFRALDH1A1MEN1KMT2AGUSB
SCHEMBL3338050 0.78 DHFR (0.52) DHFRALDH1A1MEN1KMT2AGUSB
SCHEMBL9701173 0.76 DHFR (0.62) DHFRALDH1A1GUSBGAAKDM4E
Dimethylenastron SCHEMBL5178439 0.75 ALDH1A1 (0.65) DHFRALDH1A1MEN1KMT2AGUSB
SCHEMBL13302762 0.75 DHFR (0.52) DHFRALDH1A1MEN1KMT2AGUSB
SCHEMBL12595219 0.72 TRPA1 (0.61) DHFRALDH1A1MEN1KMT2AGUSB
SCHEMBL5201966 0.69 DHFR (0.48) DHFRALDH1A1MEN1KMT2AGUSB
SCHEMBL13425344 0.68 GAA (0.57) ALDH1A1MEN1KMT2AGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2010-06-17 US disclosed
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2010-06-17 US disclosed
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2010-06-17 US disclosed
WO-2006074293-A2 BICYCLIC DIHYDROPYRIMIDINES AS EG5 INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2006-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof KIF5A, KIF5C, KIF5B DHFR 45/4885ALDH1A1 739/4885MEN1 2916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.